InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Brown Victoria L., Executive. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 8 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €115k. Activity tracked since 26 October 2021. The latest transaction was filed on 20 January 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Brown Victoria L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
1,412 shares@ US$52.0590.0% of flowCommon StockSEC:0001127602-23-002109:0
130 shares@ US$58.4110.0% of flowCommon StockSEC:0000899243-22-034414:0
2,698 shares@ US$45.000.0022% mcap73.8% of flowCommon StockSEC:0001127602-22-017990:0
82 shares@ US$49.282.6% of flowCommon StockSEC:0001127602-22-010532:0
175 shares@ US$47.125.1% of flowCommon StockSEC:0001127602-22-004777:0
434 shares@ US$38.5910.7% of flowCommon StockSEC:0001127602-22-002817:0
17,466 shares0Common StockSEC:0001127602-22-002058:0
882 shares0Common StockSEC:0001127602-21-027695:0
8 of 8 declarations
About Brown Victoria L.
Brown Victoria L. is an executive at Apellis Pharmaceuticals, Inc., where she holds the role of Program Team Lead. She has 8 filings in total, and among the sampled recent filings from 2021-10-27 to 2023-01-24, the reported volume is 0 in buys and 115115 in sells, with the most common transaction nature listed as Tax withholding.
